Arundel, United Kingdom

Ernest Lionel Rivett

This inventor holds 2 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 1999-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ernest Lionel Rivett. Retrieved from https://idiyas.com/inventor/ernest-lionel-rivett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Ernest Lionel Rivett

Introduction

Ernest Lionel Rivett is a notable inventor based in Arundel, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance drug delivery. With a total of 2 patents to his name, Rivett's work has had a meaningful impact on medical treatments.

Latest Patents

Rivett's latest patents include a "Polymer coated tablet comprising amoxycillin and clavulanate" and a "Delayed release pharmaceutical formulation containing amoxycillin." These innovations demonstrate his commitment to improving the efficacy and safety of pharmaceutical products.

Career Highlights

Ernest Rivett is associated with SmithKline Beecham Corporation, where he has been instrumental in advancing pharmaceutical research and development. His work has contributed to the creation of more effective medications, benefiting patients worldwide.

Collaborations

Throughout his career, Rivett has collaborated with esteemed colleagues such as Francis Walter Grimmett and Michael William Hartnell. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ernest Lionel Rivett's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…